Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 667,694 | 892,478 | 264,930 | 589,529 | 669,879 |
| Marketable Securities | 153,386 | 194,455 | 254,308 | N/A | N/A |
| Receivables | 8,389 | 9,981 | 7,737 | 7,731 | 6,063 |
| TOTAL | $845,454 | $1,114,760 | $541,326 | $608,497 | $684,507 |
| Non-Current Assets | |||||
| PPE Net | 123,496 | 55,323 | 54,772 | 54,896 | 50,477 |
| Investments And Advances | 142,166 | 45,944 | 15,599 | 16,887 | 17,403 |
| Intangibles | 6,531 | 5,439 | 4,191 | 3,856 | 3,914 |
| Other Non-Current Assets | 1,571 | 1,453 | 1,396 | 1,401 | 1,639 |
| TOTAL | $273,764 | $108,159 | $75,958 | $77,040 | $73,433 |
| Total Assets | $1,119,218 | $1,222,919 | $617,284 | $685,536 | $757,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 25,013 | 67,401 | 52,628 | 38,564 | 46,048 |
| Other current liabilities | 27,126 | 261 | N/A | 378 | 961 |
| TOTAL | $60,318 | $75,315 | $59,868 | $46,130 | $53,749 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 100,840 | 35,201 | 32,033 | 33,934 | 35,423 |
| TOTAL | $100,840 | $35,201 | $32,033 | $33,934 | $35,423 |
| Total Liabilities | $161,158 | $110,516 | $91,901 | $80,065 | $89,172 |
| Shareholders' Equity | |||||
| Common Shares | 8,244 | 8,384 | 7,147 | 7,108 | 7,216 |
| Retained earnings | -1,176,887 | -1,041,945 | -847,376 | -744,263 | -684,682 |
| Other shareholders' equity | 151,955 | 138,576 | 119,139 | 104,729 | 89,484 |
| TOTAL | $958,060 | $1,112,403 | $525,383 | $605,471 | $668,768 |
| Total Liabilities And Equity | $1,119,218 | $1,222,919 | $617,284 | $685,536 | $757,940 |